Nelson Peltz’s firm has held a roughly 5% stake in Solventum since the middle of last year. Solventum, which sells healthcare ...

English-Dutch food giant Unilever ousted its CEO Hein Schumacher this week, after barely one-and-a-half years on the job, and ...

Nelson Peltz’s Trian Fund Management plans to push Solventum (SOLV) to separate more of its businesses after the company sold its filtration ...

Unilever shocked the market when it announced its chief exec Hein Schumacher would be replaced by finance chief Fernando ...

Nelson Peltz’s Trian Fund Management disclosed in an SEC filing its holdings as of December 31, 2024. Trian increased its stake in a number of holdings, including by size of previous position ...

Unilever's board, which includes billionaire activist investor Nelson Peltz, was unified in its decision to oust CEO Hein ...

M spin-off Solventum forecast annual profit above analyst estimates on Thursday, betting on strong sales of its wound care and surgical sterilization products.

Activist investor Nelson Peltz's Trian Fund Management plans to push Solventum for further business separations following the company's $4.1 billion filtration unit sale, the Wall Street Journal ...

In today’s CEO Daily: Peter Vanham on activist investor Nelson Peltz and ... to CEO Daily on Wednesday, Peltz made a clear endorsement of the new CEO: “Trian believes continued operational ...

Nelson Peltz’s firm has held a roughly 5% stake in Solventum since the middle of last year. Solventum, which sells healthcare products, was spun out from 3M in April 2024.